Safety and Efficacy of SM934 Compared to Placebo in Adult Subjects With Active Systemic Lupus Erythematosus
Status:
Unknown status
Trial end date:
2020-12-31
Target enrollment:
Participant gender:
Summary
This is a single-center, randomized, double-blind, placebo-controlled, phase 2 study. The
purpose of the study is to initially evaluate the safety and efficacy of SM934 combined with
steroids compared to placebo in adult subjects with active systemic lupus erythematosus (SLE)
over a 12-week period.